Approval · Notice of Compliance 19105 · 2017
JUXTAPID: Notice of Compliance 19105
Issued March 27, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19105
- Date
- March 27, 2017
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional drug substance manufacturing site. change in manufacturing process
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JUXTAPID | Not yet assigned | — |
Medicinal ingredients
- LOMITAPIDE MESYLATE 5 MG per CAP
- LOMITAPIDE MESYLATE 10 MG per CAP
- LOMITAPIDE MESYLATE 20 MG per CAP